Leffler, MD, clinical research director of the Celiac Disease Center at Beth Israel Deaconess Medical Center in Boston, Massachusetts, told meeting attendees.

• 此药物促进前发炎性细胞激素产生，且理论上促进腔室愈合以及降低胃肠道癌症风险。